H. Aberle et al., THE HUMAN PLAKOGLOBIN GENE LOCALIZES ON CHROMOSOME 17Q21 AND IS SUBJECTED TO LOSS OF HETEROZYGOSITY IN BREAST AND OVARIAN CANCERS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(14), 1995, pp. 6384-6388
The gene encoding human plakoglobin was mapped to chromosome 17q12-q22
. An intragenic restriction fragment length polymorphism was used to l
ocalize the plakoglobin gene distal to locus KRT10 and proximal to the
marker D17S858. The plakoglobin gene colocalizes with the polymorphic
17q21 marker UM8 on the same cosmid insert. This subregion of chromos
ome 17 is known to be particularly subjected to genetic alterations in
sporadic breast and ovarian tumors. We show loss of heterozygosity of
the plakoglobin gene in breast and ovarian tumors. We have identified
a low-frequency polymorphism in the plakoglobin coding sequence which
results in an arginine to histidine substitution at amino acid positi
on 142 of the protein, as well as a silent mutation at nucleotide posi
tion 332 of the coding sequence. This polymorphism allowed us to demon
strate an allelic association of plakoglobin with predisposition to fa
milial breast and ovarian cancers. Our results, together with the pres
ent knowledge about the biological function of plakoglobin, suggest th
at plakoglobin might represent a putative tumor suppressor gene for br
east and ovarian cancers.